Mutations in Ribosomal Protein L16 Conferring Reduced Susceptibility to Evernimicin (SCH27899): Implications for Mechanism of Action
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.44.3.732-738.2000
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2000
Authors
Publisher
American Society for Microbiology